NEXRW Fail-to-Deliver
Nexera Technologies Ltd (NEXRW) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1,865, listed on NASDAQ, employing roughly 11 people, carrying a beta of 1.66 to the broader market. Nexera Technologies Ltd. Led by Eliyahu Zamir, public since 2026-03-31.
Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.
- Latest Date
- 2026-04-27
- Latest FTD Quantity
- 13
- Latest Price
- $0.02
- 30-Day Avg FTD
- 13
- 30-Day Total FTD
- 26
Showing 2 days of SEC fail-to-deliver data for Nexera Technologies Ltd.
Learn how fails-to-deliver is reported and how to read the data →
Frequently asked NEXRW fail to deliver questions
- What is the latest NEXRW fail-to-deliver count?
- As of Apr 27, 2026, Nexera Technologies Ltd (NEXRW) fail-to-deliver quantity is 13 shares, with a 2-day average of 13 shares. The SEC publishes FTD data twice monthly: first-half data at month-end, second-half around the 15th of the following month.
- What is the FTD aggregate net balance?
- FTD figures represent the aggregate net balance in NSCC's Continuous Net Settlement (CNS) system, not the gross failed-share count. The published numbers run 2-6 weeks stale relative to the underlying settlement date.
- How do NEXRW FTDs affect options pricing?
- Persistent FTDs flag hard-to-borrow conditions that distort put-call parity: in HTB names, synthetic long stock (long call + short put at the same strike) trades below the frictionless-parity price by approximately the borrow rebate. The discount equals the lending revenue forgone by holding the synthetic instead of actual shares. Reg SHO threshold-list inclusion follows from sustained FTD persistence.